Figure 2From: Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs – a systematic review and network meta-analysis Network of randomized controlled trials evaluating agents for DMARD-IR RA patients in terms of PROs at 24 weeks. Back to article page